CURA MANAGEMENT A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.3% 6.3% 7.3% 3.7% 4.5%  
Credit score (0-100)  29 36 32 51 46  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  2,982 1,914 3,069 3,466 3,213  
EBITDA  -249 206 683 647 217  
EBIT  -290 165 643 568 96.8  
Pre-tax profit (PTP)  -309.1 155.1 637.0 572.8 97.9  
Net earnings  -345.6 155.1 550.3 418.7 69.1  
Pre-tax profit without non-rec. items  -309 155 637 573 97.9  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  161 121 80.6 344 223  
Shareholders equity total  236 385 935 1,354 1,423  
Interest-bearing liabilities  19.4 25.0 194 110 16.2  
Balance sheet total (assets)  2,464 2,171 2,568 2,376 2,093  

Net Debt  -1,913 -1,298 -409 -1,321 -1,063  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,982 1,914 3,069 3,466 3,213  
Gross profit growth  -61.2% -35.8% 60.3% 12.9% -7.3%  
Employees  4 2 2 2 2  
Employee growth %  -33.3% -50.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,464 2,171 2,568 2,376 2,093  
Balance sheet change%  -46.9% -11.9% 18.3% -7.5% -11.9%  
Added value  -249.3 205.7 683.0 608.6 217.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -80 -81 -81 184 -241  

Net sales trend  -1.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 2.0 3.0 4.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -9.7% 8.6% 20.9% 16.4% 3.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -8.1% 7.1% 27.1% 23.2% 4.6%  
ROI %  -12.2% 10.5% 50.6% 44.2% 7.1%  
ROE %  -84.5% 49.9% 83.4% 36.6% 5.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  9.6% 17.7% 36.4% 57.0% 68.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  767.2% -631.0% -59.9% -204.0% -488.8%  
Gearing %  8.2% 6.5% 20.8% 8.1% 1.1%  
Net interest  0 0 0 0 0  
Financing costs %  2.1% 46.9% 5.2% 0.6% 8.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  3.2 2.6 1.5 2.0 2.8  
Current Ratio  3.2 2.6 1.5 2.0 2.8  
Cash and cash equivalent  1,932.1 1,323.2 603.2 1,430.7 1,079.4  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,575.2 1,263.7 854.3 1,014.0 1,199.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -62 103 341 304 109  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -62 103 341 324 109  
EBIT / employee  -72 83 321 284 48  
Net earnings / employee  -86 78 275 209 35